Bristol-Myers Squibb Company
Utility Patent Applications
Last updated:
List of all Bristol-Myers Squibb Company patents 438 in total
| Status | Patent |
|---|---|
Application | Utility: TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS IRAK4 INHIBITORS Filling date: 6 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: COMBINATION OF TIM-4 ANTAGONIST AND PD-1 ANTAGONIST AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY Filling date: 6 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: SUBSTITUTED QUINOLINYLCYCLOHEXYLPROPANAMIDE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION Filling date: 6 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: THIENOPYRIDINYL AND THIAZOLOPYRIDINYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS Filling date: 6 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: PYRAZOLO[3,4-D]PYRROLO[1,2-B]PYRIDAZINYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS Filling date: 6 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-- YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS Filling date: 6 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: METHODS OF IDENTIFYING A SUBJECT SUITABLE FOR AN IMMUNO-ONCOLOGY (I-O) THERAPY Filling date: 6 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: ANTI-CTLA4 ANTIBODY PRODRUGGABLE (PROBODY) AT A CDR POSITION Filling date: 6 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: IMMUNOMODULATORS Filling date: 6 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: Antibody Compositions and Methods of Use Thereof Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: METHODS OF TREATING TUMORS Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: ISOXAZOLE CARBOXYLIC ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: CYCLOBUTYL CARBOXYLIC ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: TRIAZOLE CARBOXYLIC ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: CRYSTALLINE SALT FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-- YL)PHENYL)AMINO)-N-(METHYLD3) PYRIDAZINE-3-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: CELL LOCALIZATION SIGNATURE AND COMBINATION THERAPY Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: METHODS OF MONITORING CELL CULTURE MEDIA Filling date: 6 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: METHODS FOR REGENERATING CHROMATOGRAPHY RESINS Filling date: 6 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: METHODS OF TREATING UROTHELIAL CARCINOMA USING AN ANTI-PD-1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: PRODRUG COMPOUNDS Filling date: 6 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: ANGPTL2 ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: ANTI-NKG2A ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS Filling date: 6 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: ANTI-NKG2A ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat Tumors Filling date: 6 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: ANTIBODY HEAVY CHAIN CONSTANT DOMAINS Filling date: 6 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides Filling date: 6 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: METHODS AND COMPOSITIONS FOR 18F-RADIOLABELING OF BIOLOGICS Filling date: 6 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: SMALL MOLECULE INHIBITORS OF GALECTIN-3 Filling date: 6 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: PROCESS FOR THE PREPARATION OF N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1- ,3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: AMORPHOUS AND CRYSTALLINE FORMS OF IDO INHIBITORS Filling date: 6 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: USE OF LOW PH AND DEXTRAN SULFATE DURING HARVEST TREATMENT FOR PROTEIN PURIFICATION Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: COMPOSITIONS AND METHODS OF TREATING CANCER Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: CYTOKINE PROFILING ANALYSIS Filling date: 6 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANTIBODY DIRECTED AGAINST CD28 Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: TREATMENT OF LUNG CANCER USING AN ANTI-FUCOSYL-GM1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: NOVEL SYNTHETIC OPTIONS TOWARDS THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-- 1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOL- O[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: ENHANCED PERFORMANCE OF AMORPHOUS SOLID AND SOLUBILIZED FORMULATIONS FOR ACHIEVING THERAPEUTIC PLASMA CONCENTRATIONS Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Showing 1 to 50 of 438 patents.